Lithium poisoning and renal replacement therapy: pathophysiology and current clinical recommendations

Int Urol Nephrol. 2023 Oct;55(10):2501-2505. doi: 10.1007/s11255-023-03558-5. Epub 2023 Mar 20.

Abstract

Lithium intoxication is still an undefined and underestimated disease, especially those cases requiring extracorporeal treatment. Lithium is a monovalent cation with small molecular mass of 7 Da that has been regularly and successfully used since 1950 in the treatment of mania and bipolar disorders. However, its careless assumption can lead to a wide spectrum of cardiovascular, central nervous system and kidney diseases in case of acute, acute on chronic and chronic intoxications. In fact, lithium serum range is strict between 0.6 and 1.3 mmol/L, with a mild lithium toxicity observed at the steady-state of 1.5-2.5 mEq/L, moderate toxicity when lithium reaches 2.5-3.5 mEq/L, and severe intoxication with observed serum levels > 3.5 mEq/L. Its favorable biochemical profile allows the complete filtration and partial reabsorption in the kidney due to the similarity to sodium and also the complete removal by renal replacement therapy, that should be considered in specific poisoning conditions. In this narrative and updated review we discussed a clinical case of lithium intoxication, the different pattern of diseases attributable to excessive lithium load and the current indications for extracorporeal treatment.

Keywords: Acute kidney injury; Lithium; Lithium intoxication; Nephrogenic diabetes insipidus; Renal replacement therapy; Tubulo-interstitial nephritis.

Publication types

  • Review

MeSH terms

  • Bipolar Disorder* / drug therapy
  • Heart
  • Humans
  • Kidney Diseases* / drug therapy
  • Lithium / therapeutic use
  • Renal Replacement Therapy

Substances

  • Lithium